Patient Guide: A Phase III Study Evaluating Glofitamab in Combination With Gemcitabine + Oxaliplatin vs Rituximab in Combination With Gemcitabine + Oxaliplatin in Participants With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 62 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04408638
Status: ACTIVE_NOT_RECRUITING
Condition: Diffuse Large B-cell Lymphoma
Phase: PHASE3

Where You Can Participate

This study is available at 62 locations across the country.

Top locations include:
  • • Birmingham, Alabama
  • • Fresno, California
  • • Jacksonville, Florida
  • • And 59 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Phase III Study Evaluating Glofitamab in Combination With Gemcitabine + Oxaliplatin vs Rituximab in Combination With Gemcitabine + Oxaliplatin in Participants With Relapsed/Refractory Diffuse Large B-Cell Lymphoma - Join Clinical Trial NCTNCT04408638

How to Join This Clinical Trial - NCTNCT04408638

Learn how to participate in this PHASE3 trial studying an investigational therapy for Diffuse Large B-cell Lymphoma. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Diffuse Large B-cell Lymphoma. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Diffuse Large B-cell Lymphoma
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT04408638 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 62 locations. Find a study site near you:

Clinical Research Site

Birmingham, Alabama 35294-3300 - United States

Status: Contact for availability

Clinical Research Site

Fresno, California 93720 - United States

Status: Contact for availability

Clinical Research Site

Jacksonville, Florida 32207 - United States

Status: Contact for availability

Clinical Research Site

Baltimore, Maryland 21231 - United States

Status: Contact for availability

Clinical Research Site

Boston, Massachusetts 02114 - United States

Status: Contact for availability

Clinical Research Site

Jackson, Mississippi 39216 - United States

Status: Contact for availability

Clinical Research Site

New Brunswick, New Jersey 08901 - United States

Status: Contact for availability

Clinical Research Site

New York, New York 10029 - United States

Status: Contact for availability

Clinical Research Site

Durham, North Carolina 27705 - United States

Status: Contact for availability

Clinical Research Site

Randwick, New South Wales 2031 - Australia

Status: Contact for availability

And 52 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Diffuse Large B-cell Lymphoma:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships